• Fund Type: Unit Trust
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

AXA Framlington Biotech Fund

+ Add to Watchlist

FRABIOA:LN

144.00 GBp 6.80 4.51%

As of 00:59:30 ET on 12/24/2014.

Snapshot for AXA Framlington Biotech Fund (FRABIOA)

Year To Date: +40.67% 3-Month: +16.88% 3-Year: +43.08% 52-Week Range: 95.62 - 154.30
1-Month: +2.20% 1-Year: +39.58% 5-Year: +27.36% Beta vs NBI: 0.94

Mutual Fund Chart for FRABIOA

No chart data available.
  • FRABIOA:LN 144.00
  • 1M
  • 1Y
Interactive FRABIOA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FRABIOA

AXA Framlington Biotech Fund is an authorized unit trust incorporated in the United Kingdom. The aim of the Fund is to provide long-term capital appreciation The Fund will invest principally in equity securities of companies in the biotechnology, genomic and medical research industries worldwide.

Inception Date: 11-26-2001 Telephone: 44-207-374-4100
Managers: LINDEN THOMSON / GEMMA GAME
Web Site: www.axa-framlington.com

Fundamentals for FRABIOA

NAV (on 2014-12-24) 144.00
Assets (M) (on 2014-11-27) 477.91
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 100.00

Dividends for FRABIOA

Dividend Type Omitted
Dividend Frequency Semi-Anl
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for FRABIOA

Front Load 5.50
Back Load 0.00
Current Mgmt Fee 1.75
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.95

Top Fund Holdings for FRABIOA

Filing Date: 11/28/2014
Name Position Value % of Total
Celgene Corp 634,803 46,195,200 9.600%
Amgen Inc 409,292 43,308,000 9.000%
Biogen Idec Inc 153,928 30,315,600 6.300%
Gilead Sciences Inc 457,122 29,353,200 6.100%
Vertex Pharmaceuticals Inc 325,252 24,541,200 5.100%
Regeneron Pharmaceuticals Inc 81,301 21,654,000 4.500%
Illumina Inc 169,346 20,691,600 4.300%
Alexion Pharmaceuticals Inc 150,433 18,766,800 3.900%
BioMarin Pharmaceutical Inc 293,271 16,842,000 3.500%
Incyte Corp 338,325 16,360,800 3.400%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil